WM
56
2
FLS
63
-4
SJM
9
-7
AEE
58
-5
ZBH
71
6
DGX
35
-2
AVGO
61
-3
TGNA
45
-3
CMCSA
35
8
EXPD
20
-3
PH
53
-4
LB
69
5
BRK.B
15
-3
STT
42
-17
ORCL
36
-6
PNR
47
-6
AIV
46
3
AMAT
44
-4
KO
42
-4
PFG
27
-7
WM
56
2
FLS
63
-4
SJM
9
-7
AEE
58
-5
ZBH
71
6
DGX
35
-2
AVGO
61
-3
TGNA
45
-3
CMCSA
35
8
EXPD
20
-3
PH
53
-4
LB
69
5
BRK.B
15
-3
STT
42
-17
ORCL
36
-6
PNR
47
-6
AIV
46
3
AMAT
44
-4
KO
42
-4
PFG
27
-7
Financhill
Back

Fidelity MSCI Financials Index ETF Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
42

FNCL
Fidelity MSCI Financials Index ETF

Last Price:
$67.22
Seasonality Move:
-1.89%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
42
Fidelity MSCI Financials Index ETF (FNCL) is a Sell

Is Fidelity MSCI Financials Index ETF a Buy, Sell or Hold?

  • The current Fidelity MSCI Financials Index ETF [FNCL] share price is $67.23. The Score for FNCL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FNCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FNCL Stock Price Chart

What is Fidelity MSCI Financials Index ETF's stock price today?

  • The Fidelity MSCI Financials Index ETF share price today is $67.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNCL is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $40.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.

FNCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: -141481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.45 - 71.35) Sell
Bollinger Bands (100): (63.41 - 70.49) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.44 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -2576687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.5 - 57.26) Sell
Bollinger Bands (100): (51.08 - 57.64) Sell

FNCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.63 Sell
20-day SMA: 69.4 Sell
50-day SMA: 69.95 Sell
200-day SMA: 62.79 Buy
8-day EMA: 68.61 Sell
20-day EMA: 69.3 Sell
50-day EMA: 69.07 Sell
200-day EMA: 63.52 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.44 Sell
20-day SMA: 52.35 Sell
50-day SMA: 55.3 Sell
200-day SMA: 51.01 Sell
8-day EMA: 48.54 Sell
20-day EMA: 51.52 Sell
50-day EMA: 53.69 Sell
200-day EMA: 49.87 Sell

Fidelity MSCI Financials Index ETF Earnings Growth & FNCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Fidelity MSCI Financials Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):